Bromadol BDPC CAS: 70895-01-1

CAS NO: 70895-01-1
Our products are for experime
Bromadol BDPC
CBNumber: CB82728955
Chemical Name: Cyclohexanol, 4-(4-broMophenyl)-4-(diMethylaMino)-1-(2-phenylethyl)-, hydrochloride, trans- (9CI)
Molecular Formula: C22H29BrClNO
Formula Weight: 438.82876
CAS No.: 7089
Description Review
Description
Our products are for experimental research only


Bromadol BDPC (CAS: 70895-01-1) is a relatively new and emerging drug that has gained some traction due to its potential as a highly effective pain reliever. The chemical name for Bromadol BDPC is 4-(4-bromophenyl)-4-(dimethylamino)-1-(2-phenylethyl)cyclohexanol, its molecular formula is C22H30BrNO, and its formula weight is 401.39 g/mol.

Bromadol BDPC has various other names, including Bromadol, BDPC, Bromadol HCL, 4-(4-bromophenyl)-4-(dimethylamino)-1-(2-phenylethyl)cyclohexanol hydrochloride, and BDPC HCL. It is considered to be a highly potent and effective analgesic or painkiller with a very high affinity for the mu-opioid receptor.

Bromadol BDPC is not yet an approved pharmaceutical drug in most countries around the world, but it remains popular in certain circles where it is used for recreational purposes.

Potential Effects

Bromadol BDPC acts as an analgesic by binding to and activating the mu-opioid receptor. The drug produces pain relief effects by blocking the transmission of pain signals and dampening the perception of pain throughout the body. The potential effects of Bromadol BDPC include:

  1. Strong pain relief for severe and chronic pain

  2. Deep relaxation, sedation, and euphoria

  3. Mood enhancement and depression relief

  4. Appetite suppression and weight loss

  5. Bronchodilation (relaxation of airway muscles)

  6. Increased heart rate and higher blood pressure

Bromadol BDPC is more potent than existing opioid medications like fentanyl and morphine, making it highly effective as a painkiller. However, these properties also make it more addictive and potentially more dangerous.

Product Mechanism

Bromadol BDPC is a synthetic opioid receptor agonist that binds to the mu-opioid receptor in the brain and spinal cord, producing analgesic or painkilling effects. The mu-opioid receptor is responsible for modulating pain, reward, and other physiological functions in the body.

Bromadol BDPC is also known to bind to other receptor subtypes, including the delta-opioid receptor, which can produce additional analgesic effects. The drug is highly lipophilic, allowing it to cross the blood-brain barrier quickly and bind to opioid receptors.

Bromadol BDPC has an extremely high binding affinity to mu-opioid receptors, which means it can produce potent analgesic effects at low doses. This high affinity also makes it more potent than traditional opioid painkillers and poses a risk of addiction or overdose.

Safety

Despite the potential therapeutic benefits of Bromadol BDPC, there is a high risk of adverse effects, overdose, and addiction. The drug is not yet approved for medical use in most countries, and its use is largely unregulated.

Bromadol BDPC is considered a Schedule I controlled substance by the US Drug Enforcement Administration, meaning it has a high potential for abuse and no recognized medical use.

Side Effects

The side effects of using Bromadol BDPC can be severe and long-lasting, particularly at high doses or when mixed with other drugs. Some of the common side effects of Bromadol BDPC include:

  1. Nausea and vomiting

  2. Dizziness and confusion

  3. Respiratory depression and reduced breathing rate

  4. Sedation and impaired coordination

  5. Constipation

  6. Itching and sweating

  7. Headache and drowsiness

Bromadol BDPC can also cause more serious side effects like seizures, coma, and death, particularly at high doses or when mixed with other drugs like benzodiazepines or alcohol.

Dosing Information

Due to the lack of approved medical use and limited research on Bromadol BDPC, there is no official dosing information available. However, it is believed that the drug is highly potent and requires very small doses to produce analgesic effects.

Recreational use of Bromadol BDPC is highly discouraged, and individuals should never self-medicate or experiment with this drug without proper medical supervision.

Summary

Bromadol BDPC is a highly potent and effective analgesic with strong pain-relieving properties. However, it is not yet an approved drug in most countries and has a high potential for abuse, addiction, and overdose. The drug poses severe health risks and is not recommended for recreational use. Those who suffer from chronic pain or other health problems should seek proper medical attention from qualified medical practitioners rather than self-medicate with unregulated drugs

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code